FDA Review Of Children’s Cough/Cold OTCs Has Broader Implications
This article was originally published in The Tan Sheet
FDA's review of children's over-the-counter cough/cold products will address the broader issue of whether extrapolating pediatric doses from adult dosing data is appropriate
You may also be interested in...
House appropriators want FDA to propose by Dec. 31 revised labeling for OTC pediatric cough and cold products that addresses safety and efficacy concerns.
The OTC industry must adapt to evolving market trends as the global economy recovers in order to maintain the market share it gained during the recession, said experts at a European industry conference
FDA named Ralph Tyler, currently Maryland's insurance commissioner, as the agency's new chief counsel